3E8D

Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.7 Å
  • R-Value Free: 0.268 
  • R-Value Work: 0.211 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history. 

Literature

Aminofurazans as potent inhibitors of AKT kinase

Rouse, M.B., Seefeld, M.A., Leber, J.D., McNulty, K.C., Sun, L., Miller, W.H., Zhang, S., Minthorn, E.A., Concha, N.O., Choudhry, A.E., Schaber, M.D., Heerding, D.A.

(2009) Bioorg.Med.Chem.Lett. 19: 1508-1511

  • DOI: 10.1016/j.bmcl.2009.01.002
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 

    • AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe rec ...

    AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe recent efforts focusing on investigating a distinct region of this scaffold that have afforded compounds (30 and 32) with comparable activity profiles to that of GSK690693.

    Related Citations: 
    • Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors
      Seefeld, M.A.,Rouse, M.B.,McNulty, K.C.,Sun, L.,Wang, J.,Yamashita, D.S.,Choudhry, A.,Schaber, M.D.,Kumar, R.,Kahana, J.,Zhang, S.Y.,Minthorn, E.A.,Koretke, K.K.,Concha, N.O.,Heerding, D.A.
      () TO BE PUBLISHED --: --

    Organizational Affiliation: 

    Oncology Chemistry, GlaxoSmithKline, Collegeville, PA 19426, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
RAC-beta serine/threonine-protein kinase
A, B
335Homo sapiensMutation(s): 1 
Gene Names: AKT2
EC: 2.7.11.1
Find proteins for P31751 (Homo sapiens)
Go to Gene View: AKT2
Go to UniProtKB:  P31751
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Glycogen synthase kinase-3 beta peptide
C, D
10Homo sapiensMutation(s): 0 
Gene Names: GSK3B
EC: 2.7.11.26
Find proteins for P49841 (Homo sapiens)
Go to Gene View: GSK3B
Go to UniProtKB:  P49841
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
G98
Query on G98
Download SDF File 
Download CCD File 
A, B
4-[2-(4-amino-2,5-dihydro-1,2,5-oxadiazol-3-yl)-6-{[(1S)-3-amino-1-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
C24 H29 N7 O3
LYSNCXJOXXQEIU-SFHVURJKSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
TPO
Query on TPO
A, B
L-PEPTIDE LINKINGC4 H10 N O6 PTHR
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.7 Å
  • R-Value Free: 0.268 
  • R-Value Work: 0.211 
  • Space Group: P 32
Unit Cell:
Length (Å)Angle (°)
a = 116.823α = 90.00
b = 116.823β = 90.00
c = 45.102γ = 120.00
Software Package:
Software NamePurpose
HKL-2000data reduction
JDirectordata collection
DENZOdata reduction
SCALEPACKdata scaling
PHASERphasing
PDB_EXTRACTdata extraction
REFMACrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots


View more in-depth experimental data

Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2008-10-14
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Advisory, Version format compliance
  • Version 1.2: 2014-11-19
    Type: Non-polymer description
  • Version 1.3: 2017-10-25
    Type: Refinement description